Cartography Biosciences
Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.
About Cartography Biosciences
Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens. The company provides a differentiated oncology pipeline of antibody-based therapies to target tumors more precisely than existing therapeutics. Its ATLAS and SUMMIT drug discovery platforms are powered by an industry-leading, fully integrated dataset spanning hundreds of thousands of cell states across the healthy body and large-scale profiling of individual cells from patient tumors.
Company Facts
- Headquarters
- South San Francisco
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- early_stage_venture
- Total Funding
- $124,000,000
- Last Funding Type
- series_b
- Last Funding Date
- 2025-10-02
- Website
- cartography.bio
Industries & Categories
Biopharma, Biotechnology, Life Science, Oncology
Social Links
Canonical: https://fsome.com/organization/cartography-biosciences-26015 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.